The development of pharmaceutical biotechnology in Kharkiv: to the 125th anniversary of “Biolik” enterprise
DOI:
https://doi.org/10.24959/nphj.24.128Keywords:
bibliosemantic review; pharmaceutical biotechnology; technology; historical analysis; generalization of data; vaccine; liposome; serumAbstract
Aim. To study the development of pharmaceutical biotechnology in Ukraine on the example of the history of the Kharkiv enterprise “Biolik” over the past 125 years.
Materials and methods. Analytical and comparative research methods, as well as bibliosemantic review were used in the article.
Results and discussion. The development of the scientific and technological school of the enterprise “Biolik” in the production of drugs based on biotechnology, such as vaccines, serums, probiotics, artificial nanoparticles, etc., was studied covering the period from the end of the XIX-th century and to the present time.
Conclusions. It has been shown that the enterprise “Biolik” has a significant potential (production areas, equipment, technological documentation, staff, etc.). The enterprise can produce immune-biotechnological and original medicines. We can hope that this potential of the enterprise will allow it to successfully resume the production of high-tech drugs in Ukraine.
References
Report on the activities of the Bacteriological Institute of the KhMU for 1914. (1915). Kharkiv.
Golbets, I. I. (1998). To the 100th anniversary of the Biolek enterprise. Scientific research. Collection of reports of the scientific and practical conference “Standardization, control and production of immunobiological and medicinal products”, dedicated to the 100th anniversary of the Kharkov enterprise “Biolek”». Kharkiv.
Key dates and achievements of the development of the Kharkov enterprise “Biolek”. (1998). History of the enterprise. Collection of reports of the scientific and practical conference “Standardization, control and production of immunobiological and medicinal products”, dedicated to the 100th anniversary of the Kharkov enterprise “Biolek”». Kharkiv.
History of the creation of the production of bacterial preparations. Production of bacterial preparations in the Soviet Union over 40 years. Establishment of the production of bacterial preparations in the Leningrad, Moscow, Stavropol, Perm, Tashkent, Tbilisi, Ufa, Kharkov and Dagestan Institutes of Vaccines and Serums. Available at: http://techpharm.ru/history_bac.php
Krasnopolskyi, Yu. M., Volchyk. I. V. (2013). Kharkiv enterprise «Biolik» – 115 years of serving people’s health. Pharmacom, 4. 11-16.
Krasnopolskyi, Yu. M., Volchyk. I. V. (2013). Kharkiv enterprise “Biolik” – 115 years of serving people’s health. Pharmacom, 1. 18.
Vasilyevsky, N. I., Lyubarsky, V. A., Khatenever, L. M. (ed). (1934). Guide to vaccine and serum production. Moscow.
Burgasov, P. N. (ed). (1978). Guide to vaccine and serum production. Moscow.
Dyachenko, S.S. (1989). To the 100th anniversary of the organization of the Pasteur Vaccination Institute and Bacteriological Station in Kharkov. Medical practice, 1. 118-120.
Strelnikov, L. S., Strilets, O. P., Shcherbak, E. V., Chikitkina, V. V., Dolgova, T. A. (2006). Prospects and ways of developing the production of biotechnological medicines in Ukraine. Annals of the Mechnikov Institute, 4. 3-8.
Krasnopolsky, Yu. M., Borshchevskaya, M. I. (2008). Biotechnology of immunobiological preparations. Kharkiv.
Nedrigailov, V. I. (1898). Experiments with the administration of anti-diphtheria serum per os and per rectum for therapeutic purposes. Proceedings of the Kharkov Medical Society.
Osrtianine, G. (1901). Sur les proprietes bactericides du serum sanguin dans le cours des maladies. Annales de L`Institut. Pasteur, 15. 266-278.
Korshun, S. V., Nedrigailov, V. I., Ostryanin, G. Ya. (1902). On obtaining anti-diphtheria serum rich in antitoxins. Materials of reports at the Pirogov Congress.
Nedrigailov, V. I. (1906). Methods of vaccinations in Russian Pasteur Institutes. Proceedings of the Kharkov Medical Society.
Sakovskaya, L. (1994). “Biolek can do a lot”. Pharmacy of Ukraine, 4 (33). 1-3 .
How the defense industry became friends with the pharmacy. (1998). Mirror of the week, 20 (189). 14.
Sakovska, L. (1998). Centennial, one of the most modern. Medicines and health, 18 (143). 3.
“What is it like, “Biolek”, today and tomorrow?” 92002). Medicines and health, 2-3 (254-255). 4.
Kharkov factory “Biolek” supplies high-quality drug for the diagnosis of tuberculosis. Status Quo. Available at: https://www.sq.com.ua/rus/news/no_rubric/13.04.2006/harkovskaya_fabrika_biolek_postavlyaet_kachestvennyj_preparat_dlya_diagnostiki_tuberkuleza_.
Krasnopolsky, Yu. M. (2020). Creation in Ukraine of technologies for obtaining pharmacologically active ingredients, medicinal and diagnostic preparations based on lipids. Bulletin of the National Technical University “KhPI”. Series: Chemistry, chemical technology and ecology. 1. 53- 68.
Vasilenko, I. A., Chupin, V. V., Krasnopolsky, Yu. M. (1981). Relationship between the structure and properties of cardiolipin antigen. Chemical-Pharmaceutical Journal, 15 (2). 14-18.
Patent 5654 Ukraine. Method of obtaining a liposomal drug. No. 93101191; appl. 01.14.1993; publ. 12.28.1994, Bull. 7-І.
Krasnopolsky, Yu. M. (2010). At the origins of a new direction in pharmacology – liposomepharmacology. O. V. Stefanov. Men who fulfill its purpose. Kyiv.
Krasnopolskyi, Yu. M., Shvets, V. I., Volchik, I. V. (2012). Liposomal nanoparticles as carriers of medicinal preparations. Pharmaceutical Courier, 6, 42-46.
Krasnopolsky, Yu., Pylypenko, D. (2022). Licensed liposomal vaccines and adjuvants in the antigen delivery system. BioTechnologia, 103(4). 409-423. doi: 10.5114/bta.2022.120709
Tretyakova, O. S., Zadnipryansky, I. I. (2009). Biotechnology in the practice of a cardiologist. Part II. Realities and prospects. Child health, 4(19). 12-16.
Shvets, V. I., Krasnopolsky, Yu. M. (2008). Liposomes in pharmacy. Nanotechnology products. Pharmacist, 3. 18-24.
Shvets, V. I., Krasnopolsky, Yu. M. (2008). Liposomes in pharmacy. Nanotechnology products. Pharmacist, 6. 34-37.
Grigorieva, A. S., Katsai, A. G., Konakhovich, N. F., Prokhorov, V. V.,Stadnichenko, A. V., Krasnopolsky, Yu. M., Shvets, V. I. (2016). Nanomedicine in Ukraine: 25 years of use of liposomal drugs. Farmakom, 1. 41-46.
Shvets, V. I., Kaplun, A. P., Krasnopol’skii, Yu. M., Stepanov, A. E., Chekhonin, V. P. (2008). From Liposomes of the 1970s to 21st Century Nanobiotechnology. Nanotechologies in Russia, 3 (11-12). 643-655.
Krasnopolsky, Yu. M., Stepanov, A. E., Shvets, V. I. (2009). Technological aspects of obtaining drugs under GMP conditions. Biopharmaceutical Journal, 1 (3), 18-29.
Ryzhenko, S. A., Kremenchutskyi, H. M., Kryzhanovskyi, D. G., Kozhushko, M. Yu., Dyklenko, T. V., Gamota, I. O. et al. (2009). Effect of liquid probiotic “A-Bacterin” on intestinal microbiota of persons with pulmonary tuberculosis. Medical perspectives, 14 (1). 65-68.
Krasnopolsky, Yu. M. (2009). Probiotics as part of biological dietary supplements. BAA-expert, 1. 18-22.
Khizhnyak, O. S., Krasnopolskyi, Yu. M. (2012). Biotechnological aspects of creation of preparations based on probiotics. Bulletin of NTU “KhPI”, 44 (950). 72-78.
Khizhnyak, O. S., Krasnopolskyi, Yu. M. (2013). Biotechnological aspects of obtaining a complex preparation containing different strains of probiotic cultures. Bulletin of NTU “KhPI”, 4 (978). 113-120.
Patent №5064758 USA. Method of preparing a mixture of ribonucleotides. № 462921. Appl. 20.12.1988. Publ. 12.11.1991. 4 p.
Lozynskyi, S. (1985). Competition in the avant-garde. Kharkiv evening. 291(5126).
From the laboratory to the workshops. Kharkiv evening. (1986). 325 (5400).
“Biolek”. Centuries-old traditions of quality and dynamic development. Pharmacy. (2004). 461(40).
Laureates of the 1985 State Prizes of the USSR in the field of science and technology from Kharkiv. Kharkiv evening. (1985). 263 (5098).
“Labor Glory” of the “Golden Fortune” international academic rating. 1993-2007, 15 years of Golden Fortune. Pharmacist. (2007). 18.
Krasnopolskyi, Yu. M. (2006). Materials of the “Golden Fortune” rating.
Krasnopolsky, Yu. M., Prokhorov, V. V., Volchik, I. V. (2008). On the issue of standardization and control of immunoglobulins for intravenous administration obtained from human blood plasma. Pharmacist, 10. 24-28.
Volchik, I. V., Tikhonenko, T. M., Krasnopolsky, Yu. M., Tikhonenko, N. I. (2014). Current issues of quality control of human blood plasma for fractionation in Ukraine. Scientific journal of the Ministry of Health of Ukraine, 2 (6). 85-90.
Krasnopolsky, Yu. M., Stepanov, A. E., Shvets, V. I. (2011). Lipid technological platform for the creation of new dosage forms and transport of pharmaceutical substances. Biopharmaceutical Journal. 3(2). 10-18.
Pivnuk, V. M., Tymovska, Yu. O., Ponomareva, O. V., Kulyk, G. I., Olyinichenko, G. P., Anikusko, M. F., Krasnopolsky, Yu. M., Chekhun, V. F. (2007). Applying of liposomal form of doxorubicin in patients with doxorubicin-resistant breast cancer. Oncology, 9 (2), 120-124.
Shakhmaiev, A. E., Gorbach, T. V., Bobritskaya, L. A., Krasnopolsky, Yu. M. (2015). Preparation and cardioprotective effect analysis of liposomal coenzyme Q10. The Pharma Innovation Journal, 4(9). 22-26.
Borshchevsky, G. I., Tovmasyan, E. K., Krasnopolsky, Yu. M., Grizodub, A. I. (2013). Standardization of liposomal drugs. Farmakom, 2. 5-11.
Krasnopolsky, Y. M., Dudnichenko, А. S. (2017). Experimental study of liposomal docetaxel incorporation and stability. Experimental Oncology, 39 (2). 121-123.
Pilipenko, D. M., Katsai, A. G., Prokhorov, V. V., Konakhovich, N. F., Grigorieva, A. S., Krasnopolsky, Yu. M. (2017). Studies of the antiarrhythmic activity of the liposomal form of cytochrome C. ScienceRise: Pharmaceutical Science, 3(7). 54-57.
Katsai, O. G., Ruban, O. A., Krasnopolskyi, Y. M. (2017). Preparation and in vivo evaluation of cytochrome-C-containing liposomes. Die Pharmazie, 72(12). 736-740.
Stadnichenko, O. V., Krasnopolsky, Yu. M., Yarnykh, T. G. (2017). Study of the composition of cryoprotector and technological regine in Liophilization of Liposomes with oxaliplatinum. ScienceRise: Pharmaceutical Science, 10 (6). 21-25.
Stadnichenko, A. V., Krasnopolsky, Y. M., Yarnykh, T. G. (2018). Transfer technology features and sett lement in industrial automotive of liposomal cytostatic production. Management, economics and quality assurance in pharmacy, 2 (54). 23-28.
Katsai, O., Ruban, O. Krasnopolskyi, Y. (2018). “Quality-by-Design” approach to the development of a dosage form the liposomal delivery system of cytochrome C. Pharmakeftiki, 30 (1). 76-87.
Pylypenko, D. M., Gorbach, T. V., Katsai, O. G., Grigoryeva, A. S., Krasnopolsky, Yu. M. (2019). A study of oxidative stress markers when using the liposomal antioxidant complex. Pharmakeftiki, 31 (1). 40-47.
Grigoryeva, G. S., Кrasnopolsky, Yu. М. (2020). Liposomes per se: pharmacotherapeutical status. Pharmacology and Drug Toxicology, 14 (4). 264-271. doi: 10.33250/14.04.264.
Krasnopolsky, Yu. M., Pylypenko, D. M. (2020). «Quality By Design» in liposomal drugs creation. Biotechnologia Acta. 13 (6). 5-12. doi: 10.15407/biotech13.06.005.
Pylypenko, D., Gorbach, T. Krasnopolsky, (2020). Yu. Study of antioxidant activity of liposomal forms of quercetin and curcumin ischemic heart disease. BioTechnologia, 101 (4). 273-282. doi: 10.5114/bta.2020.100420.
Krasnopolsky, Yu., Pylypenko, D., Grigoryeva, G. (2022). Nanomedicine in anticancer therapy. Bulletin of the National Technical University «KhPI». Series: Chemistry, Chemical Technology and Ecology, 1 (7). 3-13. doi: 10.20998/2079-0821.2022.01.
Krasnopolsky, Yu. M., Pylypenko, D. M. (2022). Pharmaceutical biotechnology: present and future. Kharkiv.
Krasnopolsky, Y., Pylypenko, D. (2023). Encapsulation of eucalyptus leaves phytoproducts into liposomal nanoparticles and study of their antibacterial activity against Staphylicoccus aureus in vivo. Journal of Microbiology Biotechnology and Food Science, 12 (5). e9445. doi: 10.55251/jmbfs 9445.
Krasnopolsky, Yu. M., Pylypenko, D. M. (2023). Creation of antigen and drug delivery systems based on artificial and natural lipid nanoparticles: liposomes and exosomes : monograph. Kharkiv.
JSC Biolik received the independent Business Award “Leader in the Industry 2020”. Available at: https://biolik.com.ua.
Shop Biolik Pharma. Available at: https://biolik.com.ua/shop/.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
